Article Sidebar
Views PDF: 161
Initial evaluation of the role of FDG -PET /CT in diagnosis and radiotherapy planification of nasopharyngeal carcinoma (NPC)
Main Article Content
Abstract
SUMMARY
NPC (cavum) is a common disease in the world (1% world population according to UICC) and one of leading causes of death in South China as well as in most of ASEAN countries. PET/ CT (Positron Emission Tomography/Computed Tomography) is a modern imaging modality, playing an important role in management of NPC. Applications of FDG-PET/CT in NPC are diagnosis, staging, restaging for recurrence, monitoring therapeutic response and radiotherapy planning.
Purposes: Initial evaluation of role of PET/CT in diagnosis
and radiotherapy planning for 20 NPC patients (cavum tumor).
Objects and research method: 20 patients with determined
diagnosis of NPC with anapathological results, received PET/CT
in Nuclear medicine and Oncology Center, Bach Mai hospital for
diagnosing, staging and emulating radiotherapy plan from July
2010 to January 2011.
Results: 1. FDG-PET/CT is very valuable in diagnosing and staging NPC including detection of primary tumor in metastasic patients with unknown origin; Importance of FDG uptake (SUV value) is high at cavum (mean SUV = 11.83), at metastatic ganglions (mean SUV= 8.37) helping detection, staging modified in 38.9% patients, modifying treatment way as well as better prognosing. 2. FDG-PET/CT is usefull in planning NPC radiotherapy by helping exactly BTV, without omission of regional ganglions, modifying volume of radiotherapy in 80% patients in compared with conventional emulation by CT, reducing volume of radiotherapy in 60% patients, limiting complications due to radiation. Mean GVT-PET volume is about 92.3 cm3 in compared with GTV-CT (128.4 cm3).
Conclusion: Using FDG-PET/CT is a highly effective and safe technics in diagnosing and emulating radiotherapy plans for NPC patients.
Article Details
Keywords
PET/CT, diagnosing, emulating, radiotherapy, NPC
References
1. Phan Sỹ An và cộng sự: Bài giảng Y học hạt nhân, Nhà xuất bản Y học Hà Nội, 2009, tr. 100-106.
2. Nguyễn Bá Đức: Chẩn đoán và điều trị bệnh ung thư, Nhà xuất bản Y học Hà Nội, 2009, tr. 100-111.
3. Mai Trọng Khoa, Trần Đình Hà, Phan Sỹ An, Lê Chính Đại và cộng sự (2010): Ứng dụng kĩ thuật chụp hình PET/CT trong ung thư tại Trung tâm Y học hạt nhân và Ung bướu Bệnh viện Bạch Mai, Y học thành phố Hồ Chí Minh, trang 570-579.
4. Koshy M, Paulino AC, Howell R, Schuster D, Halkar D, Davis LW: F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head and neck cancer 2005, 27(6): 494-502.
5. Edmund Kim E. Edward Jackson E. Molecular Imaging in Oncology. Springer – Verlag Berlin Heidelberg, 2007.
6. Lang O, Schneider K, Breuning A et al 1999 Head and neck cancer: value of F-18 FDG in primary staging anhd suspicion of recurrence [abstract] J Nucl Med 40 (5 Suppl):63P.
7. Ruiz F J, D Saenz – Abad, AM Hualde – Enguila. Positron Emission Tomography: Useful in Detecting Metastatic Cancer of Unknown Primary. Singapore Med J, 2005.
8. Vincent T, Devita, Jr Theodone S. Lawrence Steven A, Rosenberg Wolters Kluwer: Cancer principles and practice of oncology. Annual advances, Volume 1. Lippincott William & Wilkins; Philadelphia, USA, 2010.
9. Z.Xiang: PET/CT fusion in radiotherapy treatment planning for head and neck cancer. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition).Vol 27, No 15S (May 20 Supplement), 2009: e17046.